Tomohiko Aigase
YOU?
Author Swipe
View article: Cribriform pattern and <scp>IDC</scp> ‐P in prostate biopsies: prognostic relevance and reporting in metastatic disease
Cribriform pattern and <span>IDC</span> ‐P in prostate biopsies: prognostic relevance and reporting in metastatic disease Open
Cribriform pattern and intraductal carcinoma of the prostate are recognized adverse histological features, yet their prognostic value in treatment‐naïve metastatic disease remains uncertain. We conducted a single‐center retrospective study…
View article: Sequential Treatment and Survival Outcomes According to Abiraterone Timing in High-Risk mHSPC: A Real-World Propensity-Matched Study
Sequential Treatment and Survival Outcomes According to Abiraterone Timing in High-Risk mHSPC: A Real-World Propensity-Matched Study Open
Background The optimal timing of abiraterone acetate (AA) in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) remains unclear. Unlike previous studies comparing upfront AA with combined androgen blockade (CAB) or andro…
View article: Short-term outcomes of triplet therapy in metastatic hormone-sensitive prostate cancer in older adults: a retrospective, single-center real-world cohort study
Short-term outcomes of triplet therapy in metastatic hormone-sensitive prostate cancer in older adults: a retrospective, single-center real-world cohort study Open
View article: P221 Complete resection of post-chemotherapy residual tumor could improve the prognosis in Non-Seminomatous Germ Cell Tumors (NSGCT)
P221 Complete resection of post-chemotherapy residual tumor could improve the prognosis in Non-Seminomatous Germ Cell Tumors (NSGCT) Open